These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 22139696)
1. Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by baicalein. Li C; Kim M; Choi H; Choi J Arch Pharm Res; 2011 Nov; 34(11):1965-72. PubMed ID: 22139696 [TBL] [Abstract][Full Text] [Related]
2. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin. Cho YA; Lee W; Choi JS Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082 [TBL] [Abstract][Full Text] [Related]
3. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Shin SC; Choi JS Anticancer Drugs; 2009 Aug; 20(7):584-8. PubMed ID: 19491656 [TBL] [Abstract][Full Text] [Related]
4. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats. Piao Y; Shin SC; Choi JS Biopharm Drug Dispos; 2008 May; 29(4):245-9. PubMed ID: 18338336 [TBL] [Abstract][Full Text] [Related]
5. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Shin SC; Choi JS; Li X Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418 [TBL] [Abstract][Full Text] [Related]
6. Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein. Shin SC; Li C; Choi JS Pharmazie; 2009 Sep; 64(9):579-83. PubMed ID: 19827298 [TBL] [Abstract][Full Text] [Related]
7. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin. Choi JS; Kang KW Arch Pharm Res; 2008 Dec; 31(12):1631-6. PubMed ID: 19099234 [TBL] [Abstract][Full Text] [Related]
8. Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein. Cho YA; Choi JS; Burm JP Pharmacol Rep; 2011; 63(4):1066-73. PubMed ID: 22001996 [TBL] [Abstract][Full Text] [Related]
9. Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats. Singh SP; Wahajuddin ; Raju KS; Ali MM; Kohli K; Jain GK Phytother Res; 2012 Feb; 26(2):303-7. PubMed ID: 22131128 [TBL] [Abstract][Full Text] [Related]
10. Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Li C; Lim SC; Kim J; Choi JS Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):175-82. PubMed ID: 21442417 [TBL] [Abstract][Full Text] [Related]
11. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Shin SC; Piao YJ; Choi JS In Vivo; 2008; 22(3):391-5. PubMed ID: 18610753 [TBL] [Abstract][Full Text] [Related]
12. Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin. Choi DH; Li C; Choi JS J Pharm Pharmacol; 2010 Jul; 62(7):908-14. PubMed ID: 20636879 [TBL] [Abstract][Full Text] [Related]
13. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin. Hong SP; Chang KS; Koh YY; Choi DH; Choi JS Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809 [TBL] [Abstract][Full Text] [Related]
14. Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A. Choi JS; Choi JS; Choi DH Biopharm Drug Dispos; 2014 Oct; 35(7):382-90. PubMed ID: 24903704 [TBL] [Abstract][Full Text] [Related]
15. Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats. Li C; Kim M; Choi JS Arch Pharm Res; 2010 Sep; 33(9):1395-400. PubMed ID: 20945138 [TBL] [Abstract][Full Text] [Related]
16. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors. Yang SH; Choi JS; Choi DH Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429 [TBL] [Abstract][Full Text] [Related]
17. Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats. Kim CS; Choi SJ; Park CY; Li C; Choi JS Anticancer Res; 2010 Jan; 30(1):79-85. PubMed ID: 20150620 [TBL] [Abstract][Full Text] [Related]
18. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats. Li C; Li X; Choi JS Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886 [TBL] [Abstract][Full Text] [Related]
19. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Li X; Choi JS Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395 [TBL] [Abstract][Full Text] [Related]
20. Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats. Choi JS; Choi I; Choi DH Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):231-8. PubMed ID: 25549928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]